One such candidate has been developed by American pharmaceutical company Pfizer, which announced on Saturday with its German partner BioNotech that they proposed to expand Phase 3 clinical trials to include 44,000 participants and a more diverse patient population. Placed, which includes people up to the age of 16 years.
The proposal, which would require approval by the Food and Drug Administration, would allow companies to collect more data on the safety and efficacy of the vaccine candidate while diversifying the pool of participants.
“I think we should strive for a more diverse population as possible,” Pfizer CEO Albert Borla told CBS on Sunday on “Face the Nation”, emphasizing the importance of a diverse group of volunteers as Kovid-19 Influenced. Communities of color.
Borla told CBS that there was a “fairly good chance” that the team testing the vaccine candidate would know if it worked until the end of October. But when asked if people would have to wait until 2021 to get the vaccine, Borla said he did not know how long it might take for regulators to approve it.
Director of the National Institute of Allergy and Infectious Diseases, Drs. Anthony Fauci – who is working with Modern on his own vaccine candidate – said on Friday he remains “cautiously optimistic” that a vaccine will be ready by the end of the year.
But meeting high demand will present its own logistic challenges, and Fauci said that life before 2021 is unlikely to be normal.
“It’s not going to turn the switch off and on,” he told CNN’s Wolf Blitzer. “It’s going to be gradual and I think it’s going to take us several months before we get to the point where we can actually feel something that tells what it’s normally like before Kovid-19 Was. “
35 vaccines in human trials
The fact that detection of a coronavirus virus is very important has led to an accelerated timeline for vaccine development, raising some concerns over safety.
“In such large trials, it is expected that some participants will become unwell and every case must be carefully evaluated to ensure a careful assessment of safety,” Oxford said in a statement.
Director of the National Institutes of Health of America, Dr. Francis Collins said during a vaccine test Wednesday that this was a standard precaution. He said this is to ensure that experimental vaccines do not cause severe reactions.
Semester starts after college town conflict
While many colleges have moved classes online, it is not necessary to prevent students from gathering. And now some college cities are struggling with the Kovid-19 outbreak as the start of the fall semester complicates local responses to the epidemic.
“We do everything we can to stop the spread of COVID-19,” said MSU Physician David Weissmantle. “” The safety of our entire community is a priority and we all have a role in preventing the spread of the virus. ”
Home to the University of Georgia – Athens-Clarke County, Georgia Mayor Kelly Gertz said, CNN reported Saturday that her city saw a “dramatic spike” in cases after maintaining a low summer case count and death count is. UGA classes began August 20.
“Clearly, this is a return to campus with a large number of students who are not here during the summer,” he said.
CNN’s Lauren Mascarenhas, Naomi Thomas, Maggie Fox and John Bonifield contributed to this report.